Santa Cruz Biotechnology features a diverse variety of PGLS Antibodies for advanced research in protein function and regulation. PGLS Antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphoglycerate mutase-like protein (PGLS) plays a crucial role in cellular metabolism, particularly in the conversion of 2-phosphoglycerate to 3-phosphoglycerate, which is essential for glycolysis and gluconeogenesis. PGLS function is vital for maintaining energy homeostasis and supporting various metabolic pathways. Dysregulation of PGLS has been implicated in several diseases, making it an important target for research. PGLS monoclonal antibodies enable precise detection and quantification in experimental settings. Researchers can effectively track PGLS expression patterns across different cell types and tissues. Understanding PGLS behavior and regulation contributes to developing new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for PGLS support researchers worldwide in advancing our understanding of cellular metabolism and disease mechanisms.